Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship

被引：5

作者：

Bonafoux, Dominique F. ^{[1
]}

Bonar, Sheri L. ^{[2
]}

Clare, Michael ^{[1
]}

Donnelly, Ann M. ^{[2
]}

Glaenzer, Jeanette L. ^{[1
]}

Guzova, Julia A. ^{[2
]}

Huang, He ^{[1
]}

Kishore, Nandidni N. ^{[2
]}

Koszyk, Francis J. ^{[1
]}

Lennon, Patrick J. ^{[1
]}

Libby, Adam ^{[1
]}

Mathialagan, Sumathy ^{[2
]}

Oburn, David S. ^{[1
]}

Rouw, Sharon A. ^{[2
]}

Sommers, Cynthia D. ^{[2
]}

Tripp, Catherine S. ^{[2
]}

Vanella, Lori J. ^{[2
]}

Weier, Richard ^{[1
]}

Wolfson, Serge G. ^{[1
]}

Huang, Horng-Chih ^{[1
]}

机构：

[1] Pfizer Inc, Dept Med Chem, St Louis, MO 63017 USA

[2] Pfizer Inc, Dept Biol, St Louis, MO 63017 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2010年 / 18卷 / 01期

关键词：

IKK2; NFkB; Inhibitor; NF-KAPPA-B; IKK-2; INHIBITOR; DISCOVERY;

D O I：

10.1016/j.bmc.2009.10.040

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and in IL-1 beta stimulated synovial. broblasts. The 2-amino-5-chloropyridine-4-carboxamides were identified as the most potent inhibitors with improved cellular activity. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：403 / 414

页数：12

共 50 条

[21] Structure-activity Relationship Studies on Inhibitors of Dihydroorotate Dehydrogenase Based on Pharmacophore Model
Bao Hong-Juan
Tang Ya-Lin
Xu Xiao-Jie
Xiang Jun-Feng
Zheng Zhi-Hui
Lu Xin-Hua
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2010, 31 (05): : 938 - 946
[22] Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening
Okamoto, Masako
Takayama, Kiyoshi
Shimizu, Tomoko
Muroya, Ayumu
Furuya, Toshio
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (07) : 2728 - 2734
[23] Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances
Fu, Kaishuo
Bai, Zhifeng
Chen, Lanlan
Ye, Wenchong
Wang, Meizhu
Hu, Jiliang
Liu, Chunhui
Zhou, Wen
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
[24] Structure-Based Quantitative Structure-Activity Relationship Studies of Checkpoint Kinase 1 Inhibitors
Du, Juan
Xi, Lili
Lei, Beilei
Lu, Jing
Li, Jiazhong
Liu, Huanxiang
Yao, Xiaojun
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2010, 31 (15) : 2783 - 2793
[25] Design, Synthesis and Structure-Activity Relationship Study of Aldose Reductase Inhibitors Based on Quinoxalinone Structure
Ma B.
Fan Z.
Wang X.
Li C.
Zhu C.
Beijing Ligong Daxue Xuebao/Transaction of Beijing Institute of Technology, 2021, 41 (04): : 445 - 450
[26] Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer
Dong, Ze
Wang, Zhen
Guo, Zhong-Qiang
Gong, Shouzhe
Zhang, Tao
Liu, Jiang
Luo, Cheng
Jiang, Hualiang
Yang, Cai-Guang
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4849 - 4866
[27] Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors
Schafer, Kelsey N.
Murale, Dhiraj P.
Kim, Kibong
Cisek, Katryna
Kuret, Jeff
Churchill, David G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3273 - 3276
[28] Structure-Activity Relationship of Peptide Inhibitors of the Wnt/frizzled interaction
Blankesteijn, W. Matthijs
Hermans, Kevin C. M.
Fernandez-Llamazares, Ana Iris
Kriek, Nicole
Timmerman, Peter
FASEB JOURNAL, 2016, 30
[29] Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi
Cinque, GM
Szajnman, SH
Zhong, L
Docampo, R
Schvartzapel, AJ
Rodriguez, JB
Gros, EG
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (09) : 1540 - 1554
[30] Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors
Sonawane, Yogesh A.
Zhu, Yingmin
Garrison, Jered C.
Ezell, Edward L.
Zahid, Muhammad
Cheng, Xiaodong
Natarajan, Amarnath
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11): : 1183 - 1187

← 1 2 3 4 5 →